Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan

Japanese Journal of Infectious Diseases

Volumn 60, Issue 2-3, 2007, Pages 113-117

  Fujisaki, Seiichiro ^a   Fujisaki, Saeko ^a   Ibe, Shiro ^a   Asagi, Tsukasa ^b   Itoh, Toshihiro ^b   Yoshida, Shigeru ^c   Koike, Takao ^c   Oie, Masayasu ^d   Kondo, Makiko ^e   Sadamasu, Kenji ^f   Nagashima, Mami ^f   Gatanaga, Hiroyuki ^g   Matsuda, Masakazu ^h   Ueda, Mikio ⁱ   Masakane, Aki ⁱ   Hata, Mami ^j   Mizogami, Yasushi ^k   Mori, Haruyo ^l   Minami, Rumi ^m   Okada, Kiyomi ⁿ   Watanabe, Kanako ^o   Shirasaka, Takuma ^k   Oka, Shinichi ^g   Sugiura, Wataru ^h   Kaneda, Tsuguhiro ^a   more..

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^h NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

ⁱ ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^j AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^k OSAKA NATIONAL HOSPITAL   (Japan)

^l OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^m NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

ⁿ Kitasato Otsuka Biomedical Assay Laboratories Co Ltd   (Japan)

^o Niigata Prefectural Institute of Public Health And Environmental Sciences   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ACCURACY; ANALYTICAL ERROR; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; ELECTROPHORESIS; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; JAPAN; MOLECULAR CLONING; NONHUMAN; QUALITY CONTROL; RELIABILITY; VIRUS DETECTION; VIRUS MUTATION; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; JAPAN; LABORATORIES; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SPECIMEN HANDLING;

EID: 34347348049     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Durant, J., Clevenbergh, P., Halfon, P., et al. (1999): Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet, 353, 2195-2199.
2. Baxter, J.D., Mayers, D.L., Wentworth, D.N., et al. (2000): A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. AIDS, 14, F83-93.
3. Cingolani, A., Antinori, A., Rizzo, M.G., et al. (2002): Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA). AIDS, 16, 369-379.
4. Sugiura, W. (2002): Clinical utility of drug resistance testing. Jpn. J. Clin. Med., 60, 703-710 (in Japanese).
5. Tural, C., Ruiz, L., Holtzer, C., et al. (2002): Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. AIDS, 16, 209-218.
6. Shirasaka, T., Kavlick, M.F., Ueno, T., et al. (1995): Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA, 92, 2398-2402.
7. Nagal, H., Wada, K., Morishita, T., et al. (2005): New estimation method for highly sensitive quantitation of human immunodeficieney virus type 1 DNA and its application. J. Virol. Methods, 124, 157-165.
8. Johnson, V.A., Brun-Vezinet, F., Clotet, B., et al. (2005): Update of the drug resistance mutations in HIV-I. Top. HIV Med., 13, 51-57.
9. Peters, S., Munoz, M., Yerly, S., et al. (2001): Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J. Virol., 75, 9644-9653.
10. Kaufmann, G.R., Suzuki, K., Cunningham, P., et al. (2001): Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs. AIDS Res. Hum. Retroviruses, 17, 487-497.
11. Gallego, O., de Mendoza, C., Corral, A., et al. (2003): Changes in the human immunodeficiency virus p7-p1-p6 gag gene m drug-naive and pretreated patients. J. Clin. Microbiol., 41, 1245-1247.